Research analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Trading Up 0.0 %
Shares of NYSE:BTX opened at $0.21 on Friday. Brooklyn ImmunoTherapeutics has a 12-month low of $0.17 and a 12-month high of $10.10. The business has a 50 day moving average of $0.94 and a two-hundred day moving average of $1.50. The company has a market capitalization of $12.07 million, a PE ratio of -0.19 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
Recommended Stories
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Insider Trading – What You Need to Know
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is the Dow Jones Industrial Average (DJIA)?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.